Day: June 27, 2024

Kura Sushi USA Announces Preliminary Unaudited Fiscal Third Quarter 2024 Financial Results

Kura Sushi USA Announces Preliminary Unaudited Fiscal Third Quarter 2024 Financial Results

IRVINE, Calif., June 27, 2024 (GLOBE NEWSWIRE) —  Kura Sushi USA, Inc. (“Kura Sushi” or the “Company”) (NASDAQ: KRUS), a technology-enabled Japanese restaurant concept, today announced preliminary unaudited results for the third quarter of fiscal 2024. Preliminary Unaudited Fiscal Third Quarter 2024 Financial Results The Company is announcing that it now expects to report the following results for the fiscal third quarter of 2024: Total sales are expected to be approximately $63.1 million; Comparable restaurant sales are expected to have increased approximately 0.6% for the third quarter of 2024 as compared to the third quarter of 2023; and Restaurant-level operating profit* is expected to be approximately 20% of sales. * Restaurant-level operating profit is a non-GAAP measure and is defined below under “Key Financial Definitions.”...

Continue reading

Dynagas LNG Partners LP Reports Results For the Three Months Ended March 31, 2024

Dynagas LNG Partners LP Reports Results For the Three Months Ended March 31, 2024

ATHENS, June 27, 2024 (GLOBE NEWSWIRE) — Dynagas LNG Partners LP (NYSE: “DLNG”) (the “Partnership”), an owner and operator of liquefied natural gas (“LNG”) carriers, today announced its results for the three months ended March 31, 2024. Quarter Highlights: Net Income and Earnings per common unit (basic and diluted) of $11.8 million and $0.23, respectively; Adjusted Net Income(1) of $12.4 million and Adjusted Earnings per common unit(1) (basic and diluted) of $0.25; Adjusted EBITDA(1)   $29.0 million; 100% fleet utilization(2); and Declared and paid a cash distribution of $0.5625 per unit on its Series A Preferred Units (NYSE: “DLNG PR A”) for the period from November 12, 2023 to February 11, 2024 and $0.71764025 per unit on the Series B Preferred Units (NYSE: “DLNG PR B”) for the period from November 22, 2023 to February 21,...

Continue reading

Accolade Announces Results for Fiscal First Quarter 2025

Accolade Announces Results for Fiscal First Quarter 2025

SEATTLE, June 27, 2024 (GLOBE NEWSWIRE) — Accolade, Inc. (NASDAQ: ACCD) today announced financial results for the fiscal first quarter ended May 31, 2024. “Accolade’s physician-led advocacy approach to solving the Physician Gap is increasing accessibility to healthcare and improving outcomes for the millions of lives we service. We will continue to push our leadership in Healthcare AI and a proven engagement model that is driving sustainable and profitable growth. Our focus remains on delivering a superior member experience and executing against our long term objectives to make an impact of all of our members’ lives,” said Rajeev Singh, Accolade Chairman of the Board of Directors and Chief Executive Officer. Financial Highlights for Fiscal First Quarter ended May 31, 2024   Three months ended May 31,   % Change(2)     2024       2023       (in...

Continue reading

Eliem Therapeutics Announces the Closing of its Acquisition of Tenet Medicines and Concurrent $120 Million Private Placement

Eliem Therapeutics Announces the Closing of its Acquisition of Tenet Medicines and Concurrent $120 Million Private Placement

Eliem to focus on advancing TNT119, an anti-CD19 antibody designed to treat a broad range of autoimmune diseases, including systemic lupus erythematosus, immune thrombocytopenia and membranous nephropathy Post-close cash and cash equivalents of $220 million expected to fund operations into 2027, to enable the potential attainment of key clinical and development milestones for TNT119 Announces the appointments of Dr. Aoife Brennan as President, Chief Executive Officer and Director, and Dr. Jan Hillson as Senior Clinical Advisor; Dr. Stephen Thomas, former Tenet CEO, appointed to Eliem’s Board of Directors SEATTLE and CAMBRIDGE, United Kingdom, June 27, 2024 (GLOBE NEWSWIRE) — Eliem Therapeutics, Inc. (Nasdaq: ELYM) (“Eliem”), today announced the closing of its acquisition with Tenet Medicines (“Tenet”). The transaction closed on...

Continue reading

Nokia Corporation: Repurchase of own shares on 27.06.2024

Nokia Corporation: Repurchase of own shares on 27.06.2024

Nokia CorporationStock Exchange Release27 June 2024 at 22:30 EEST Nokia Corporation: Repurchase of own shares on 27.06.2024 Espoo, Finland – On 27 June 2024 Nokia Corporation (LEI: 549300A0JPRWG1KI7U06) has acquired its own shares (ISIN FI0009000681) as follows: Trading venue (MIC Code) Number of shares Weighted average price / share, EUR* XHEL 454,376 3.50 CEUX – – BATE – – AQEU – – TQEX – – Total 454,376 3.50 * Rounded to two decimals On 25 January 2024, Nokia announced that its Board of Directors is initiating a share buyback program to return up to EUR 600 million of cash to shareholders in tranches over a period of two years. The first phase of the share buyback program in compliance with the Market Abuse Regulation (EU) 596/2014 (MAR), the Commission Delegated Regulation...

Continue reading

Integer Schedules Second Quarter 2024 Earnings Release and Conference Call for July 25, 2024

Integer Schedules Second Quarter 2024 Earnings Release and Conference Call for July 25, 2024

PLANO, Texas, June 27, 2024 (GLOBE NEWSWIRE) — Integer Holdings Corporation (NYSE:ITGR) announced today that it plans to release financial and operational results for second quarter 2024 at 7 a.m. Central Time (CT) / 8 a.m. Eastern Time (ET) on Thursday, July 25, 2024. Following the release, Integer management will host a webcast at 8 a.m. CT / 9 a.m. ET to discuss these results. Other forward-looking and material information may also be discussed during this call. Conference call details: Date: Thursday, July 25, 2024 Time: 8 a.m. CT / 9 a.m. ET Domestic dial-in number: (800) 715-9871 International dial-in number: (646) 307-1963 Conference ID: 4525826 Webcast Registration: Q2 2024 Integer Holdings Corporation Earnings Call An audio replay will be available for seven days and can be accessed by dialing (800) 770-2030 or (609)...

Continue reading

Graf Global Corp. Announces Closing of $230 Million Initial Public Offering Including Full Exercise of Underwriters’ Over-Allotment Option

Graf Global Corp. Announces Closing of $230 Million Initial Public Offering Including Full Exercise of Underwriters’ Over-Allotment Option

THE WOODLANDS, TX, June 27, 2024 (GLOBE NEWSWIRE) — Graf Global Corp. (the “Company”) today announced the closing of its initial public offering of 23,000,000 units, which includes 3,000,000 units issued pursuant to the exercise by the underwriters of their over-allotment option in full. The offering was priced at $10.00 per unit, resulting in gross proceeds of $230,000,000. The units are listed on the NYSE American LLC (“NYSE”) and commenced trading under the ticker symbol “GRAF.U” on June 26, 2024. Each unit consists of one Class A ordinary share and one-half of one redeemable warrant, with each whole warrant exercisable to purchase one Class A ordinary share at a price of $11.50 per share. Only whole warrants will be exercisable. Once the securities comprising the units begin separate trading, the Class A ordinary shares and...

Continue reading

Trifork acquires Sapere Group ApS to grow expertise in the SAP Business Technology Platform

Trifork acquires Sapere Group ApS to grow expertise in the SAP Business Technology Platform

Press releaseTrifork Group AGSchindellegi, Switzerland – 27 June 2024 Trifork acquires Sapere Group ApS to grow expertise in the SAP Business Technology Platform Trifork A/S (“Trifork”) and Sapere Group ApS (“Sapere”) today signed an agreement under which Trifork acquires 77.8% of Sapere, a Danish expert in the SAP Business Technology Platform. As partners, Trifork and Sapere will work closely together to help our SAP customers maximize the value of SAP BTP and through innovative solutions increase the overall value of their SAP investments. Strategic rationaleOver the past years, Sapere has developed highly skilled capabilities in the SAP Business Technology Platform, providing customers with integration services and architectural advisory. The ambition with the partnership is to be a full-service provider of SAP integration and solutions...

Continue reading

Correction: Denali Capital Acquisition Corp. and Longevity Biomedical, Inc. Mutually Agreed to Terminate the Business Combination

Correction: Denali Capital Acquisition Corp. and Longevity Biomedical, Inc. Mutually Agreed to Terminate the Business Combination

NEW YORK, June 27, 2024 (GLOBE NEWSWIRE) — Denali Capital Acquisition Corp. (NASDAQ: DECA) (“Denali” or the “Company”) announced today that Denali and Longevity Biomedical, Inc. have mutually agreed to terminate their previously announced business combination agreement (the “Business Combination Agreement”).  The Company and its sponsor intend to seek alternative ways to consummate an initial business combination. About Denali Capital Acquisition Corp. Denali Capital Acquisition Corp. is a blank check company incorporated as a Cayman Islands exempted company for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses or entities. Forward-Looking Statements This press release includes forward looking...

Continue reading

WestBond Reports Financial Results for the Year ended March 31, 2024

WestBond Reports Financial Results for the Year ended March 31, 2024

DELTA, British Columbia, June 27, 2024 (GLOBE NEWSWIRE) — WestBond Enterprises Corporation (TSX-V: WBE) has posted a loss of $210,683 for the year ended March 31, 2024 ($574,550 profit for the year ended March 31, 2023). Sales decreased 16.9% to $9,219,948 this year compared to $11,089,793 for the year ended March 31, 2023. The decrease in revenue and profit is the result of orders not being shipped due to a shortage of warehouse and shipping personnel. The company has subsequently hired additional production staff and materials handling personnel to reduce or eliminate this bottleneck. Sales continue to grow in all converted product categories and revenues are expected to increase. Several new markets in the US and Canada have been established in the food service industry. The company continues to focus on this market segment...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Cookie Notice

We use cookies to improve your experience on our website

Information we collect about your use of Goldea Capital website

Goldea Capital website collects personal data about visitors to its website.

When someone visits our websites, we use a third party service, Google Analytics, to collect standard internet log information (such as IP address and type of browser they’re using) and details of visitor behavior patterns. We do this to allow us to keep track of the number of visitors to the various parts of the sites and understand how our website is used. We do not make any attempt to find out the identities or nature of those visiting our websites. We won’t share your information with any other organizations for marketing, market research or commercial purposes and we don’t pass on your details to other websites.

Use of cookies
Cookies are small text files that are placed on your computer or other device by websites that you visit. They are widely used to make websites work, or work more efficiently, as well as to provide information to the owners of the site.